Culture and art
TWSC Showcases Full-Stack Customization at Global Sources Consumer Electronics Show
HONG KONG,April 14,2025-- On April 11,2025,TWSC showcases full-stack customization capabilities at Global Sources Consumer Electronics Show,highlighting AI PC and QLC NAND flash memory innovations to
Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to €350,000
Created todistinguish the most remarkable scientific discoveries in the biomedical field,this international award has been granted a growing reputation as a prelude to the Nobel Prize since it has di
CleverTap Acquires rehook.ai to Strengthen AI-Driven Promotions and Customer Retention Capabilities
The integration of rehook.ai\'s innovative promotions engine unifies analytics,engagement,and promotions,boosting AI-driven campaigns and customer retention
Wanglaoji Launches WALOVI English Brand Identity in Kuala Lumpur to Strategically Expand in Malaysian Market
GUANGZHOU,China,April 15,2025-- Recently,Wanglaoji Great Health Industry Co.Ltd. (hereinafter referred to as "Wanglaoji"),a leading Chinese natural herbal beverage enterprise,accelerated its
Bosch partners with X-Motors and CATL to Open the First Bosch Car Service Flagship Store in Indonesia
Innovative Collaboration Model Empowers ChineseAutomakers for High-Quality Global Expansion SHANGHAI,April 15,2025-- Bosch,a leading global supplier of technology and services,signed a master license
French May Arts Festival 2025, French GourMay Food and Wine Festival 2025 Holds Successful Press Conference to Commemorate This Year's Programmes
Hong Kong\'s May mega event bolsters East-West cultural bonds with the best of French art,cinema,circus,music,dance,theatre and gastronomy
The Malaysia Gifts Fair 2025 Celebrates Its 15th Anniversary
Shaping the Future of Sustainable & Innovative Gifting KUALA LUMPUR,Malaysia,April 15,2025-- The Malaysia Gifts Fair 2025 is set to commemorate a significant milestone as it celebrates its 15th An
SECuRE trial update: First patient treated in the Phase II Cohort Expansion
HIGHLIGHTS The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of theSECuRE trial has been treated with their first dose of 8 GBq of 67Cu-SAR-bisPSMA.This follows the re
XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials
SUZHOU,China,April 15,2025-- In January 2025 (U.S. time),the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submitted by XellSmart Biopharma
Grand Stevie Winners Announced in 2025 Asia-Pacific Stevie® Awards
FAIRFAX,Va.,April 16,2025-- The Stevie® Awards,organizer of the world\'s premier business awards programs,announced the winners of five Grand Stevie® Award trophies in the 12th annual Asia-Pac